NCT00532116View on ClinicalTrials.gov

PK Comparison of 6mg and 12mg EMSAM in Elderly vs. Non-Elderly

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 30, 2007

Study Completion Date

August 31, 2007

Conditions
Healthy
Interventions
DRUG

EMSAM (Selegiline Transdermal System) 6mg

STS 6mg/24hr

DRUG

EMSAM (Selegiline Transdermal System) 12mg

EMSAm 12mg/24Hr

Trial Locations (1)

Unknown

Covance Clinical Research Unit, Honolulu

Sponsors
All Listed Sponsors
lead

Somerset Pharmaceuticals

INDUSTRY